These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. Fröhlich JM J Magn Reson Imaging; 2004 Mar; 19(3):375-6; author reply 376. PubMed ID: 14994308 [No Abstract] [Full Text] [Related]
6. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959 [TBL] [Abstract][Full Text] [Related]
7. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media. Marin D; Brancatelli G; Federle MP; Lagalla R; Catalano C; Passariello R; Midiri M; Vilgrain V Clin Radiol; 2008 May; 63(5):577-85. PubMed ID: 18374723 [TBL] [Abstract][Full Text] [Related]
8. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Grazioli L; Morana G; Federle MP; Brancatelli G; Testoni M; Kirchin MA; Menni K; Olivetti L; Nicoli N; Procacci C Radiology; 2001 Dec; 221(3):731-9. PubMed ID: 11719669 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Fowler KJ; Brown JJ; Narra VR Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400 [TBL] [Abstract][Full Text] [Related]
10. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging. Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278 [TBL] [Abstract][Full Text] [Related]
11. MRI of intralesional hemolysis in focal nodular hyperplasia of the liver. Mahfouz AE; Rahmouni A; Terem C; Cherqui D; Mathieu D; Chariot P; Nhieu JT; Vasile N J Comput Assist Tomogr; 1999; 23(5):684-6. PubMed ID: 10524845 [TBL] [Abstract][Full Text] [Related]
12. Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging. Marin D; Iannaccone R; Laghi A; Catalano C; Murakami T; Hori M; Kim T; Passariello R J Magn Reson Imaging; 2007 Apr; 25(4):775-82. PubMed ID: 17348002 [TBL] [Abstract][Full Text] [Related]
13. Focal nodular hyperplasia of the liver: diffusion-weighted magnetic resonance imaging characteristics using high b values. Dohan A; Soyer P; Guerrache Y; Hoeffel C; Gavini JP; Kaci R; Boudiaf M J Comput Assist Tomogr; 2014; 38(1):96-104. PubMed ID: 24424559 [TBL] [Abstract][Full Text] [Related]
16. Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. Kuo YH; Wang JH; Lu SN; Hung CH; Wei YC; Hu TH; Chen CH; Yen YH; Lee CM; Eng HL J Clin Ultrasound; 2009; 37(3):132-7. PubMed ID: 18855931 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of enhancement patterns of focal nodular hyperplasia in contrast-enhanced, wide-band phase-inversion harmonic power Doppler imaging of the liver. Janica J; Serwatka W; Polaków J; Ustymowicz A; Walecki J; Ladny JR; Dobrzycki S Med Sci Monit; 2004 Jun; 10 Suppl 3():17-21. PubMed ID: 16538193 [TBL] [Abstract][Full Text] [Related]
18. Hepatic focal nodular hyperplasia: the "star sign" on gadolinium-enhanced magnetic resonance angiography. Ko SF; Ng SH; Lee TY; Wan YL; Lin JW; Chen CL Hepatogastroenterology; 2002; 49(47):1377-81. PubMed ID: 12239946 [TBL] [Abstract][Full Text] [Related]
19. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Grazioli L; Morana G; Kirchin MA; Schneider G Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857 [TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients. Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]